High-flow Nasal Oxygenation During Preoxygenation and Atelectasis
The Effect of High-flow Nasal Cannula Applied During Preoxygenation for Prevention of Atelectasis in Patients With Obesity Undergoing General Anesthesia: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: TAE KYONG KIM
- Phone Number: 82-2-870-2519
- Email: ktkktk@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 07061
- Recruiting
- SMG - SNU Boramae Medical Center
-
Contact:
- Tae Kyong Kim, MD
- Phone Number: 82-2-2072-2467
- Email: ktkktk@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults patients undergoinig surgery under general anesthesia with a BMI of 30 kg/m2 or greater who have given informed consent
Exclusion Criteria:
- surgery time less than 2 hours
- Nasotracheal intubation
- Severe cardiac or respiratory disease
- History of difficult airway
- History of a surgery or anatomical anomaly in the head and neck
- History of Inability to breathe through nose
- Gastric reflux disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: facemask
preoxygenation using a conventional facemask
|
preoxygenation using facemask, FIO2 1.0, fresh gas flow 10 L/min, 3 min
|
|
Experimental: high-flow nasal oxygen
preoxygenation using high-flow nasal cannula oxygen
|
preoxygenation using high-flow nasal oxygen, FiO2 1.0, 40 L/min, 3 min
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung ultrasound score
Time Frame: Immediately after anesthesia induction
|
modified LUSS
|
Immediately after anesthesia induction
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of atelectasis
Time Frame: Immediately after anesthesia induction
|
Immediately after anesthesia induction
|
|
|
PaO2 to FiO2 ratio and PaCO2
Time Frame: Immediately after anesthesia induction
|
Immediately after anesthesia induction
|
|
|
Hemodynamic variables
Time Frame: During anesthesia induction
|
Blood pressure, heart rate, pulse oximetry
|
During anesthesia induction
|
|
Patient Satisfaction Score
Time Frame: During preoxygenation
|
During preoxygenation
|
|
|
Lung ultrasound score
Time Frame: In the PACU after surgery
|
In the PACU after surgery
|
|
|
Incidence of Spo2 less than 95%
Time Frame: during 48 hours postoperatively
|
during 48 hours postoperatively
|
|
|
Maximum body temperature
Time Frame: during hospitalization up to 1 week
|
during hospitalization up to 1 week
|
|
|
Incidence of postoperative pulmonary complications
Time Frame: during hospitalization up to 1 week
|
during hospitalization up to 1 week
|
|
|
length of hospital stay
Time Frame: up to 1 year
|
up to 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: TAE KYONG KIM, SMG-SNU Boramae Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HFNO_PRE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.